M&A I Sell side I Private Equity Recapitalizations I Strategic Advisory

Private Equity Deals – Considerations of the Advantages of IRC Section 721

4min

Private Equity Deals – Considerations of the Advantages of IRC Section 721

Private Equity Deals – Considerations of the Advantages of IRC Section 721

In the current M&A climate, it is very typical for private equity groups to form LLCs before acquiring target businesses. It’s also very common to package equity in the newly formed acquiring LLC as part of the purchase price of the Target Business. In cases where existing management will continue to be involved in running the business for a pre-determined period, this equity acts as an incentive to keep them engaged, growth-minded and allows for the deferral of a portion of the gain on sale to the target owners by way of Internal Revenue Code Section 1.721-1 (Section 721).

 

Section 721 states that no gain or loss shall be recognized either to the Partnership (LLC) or to any of its partners upon the contribution of property, whether an existing partnership or newly formed. Obviously, the most common application of this code section is when two or more individuals come together to form a partnership; however, it can be of great benefit as a component of structuring business acquisitions by private equity.

 

Consider the following example:

 

Four shareholders of a large medical group agree to sell the practice in a deal put together via private equity. The established purchase price is $50 Million. The deal is structured as an asset purchase and allocated as follows:

 

                        Inventory                                            $1 Million

                        Equipment/Fixed Assets            $10 Million

                        Intangibles/Goodwill                   $39 Million

 

The shareholders will be paid $35 Million in cash and allocated a membership interest in the new acquisition LLC of $15 Million. The Doctors agree to work in the practice for the next five years, and the existing management group will stay in place.

 

The shareholders would be immediately taxable on the cash portion received for the assets, and the treatment of gain (ordinary or long-term capital gains rates) would be based on the asset classification (ordinary for the inventory, a combination of ordinary and long-term capital gains for the equipment sale based on prior depreciation methods subject to recapture rules and long-term capital gain for the Goodwill portion of the sale). The $15 Million would be considered rollover equity, and the taxability of this portion of the proceeds would be deferred until they dispose of the equity.

 

In order to pass IRS scrutiny, some logistical rules must be adhered to. First, the rollover equity must be issued in the name of the target medical practice. It would be carried on the balance sheet as an asset (investment in the new LLC). If the equity were transferred directly to the shareholders, it would become taxable immediately as a distribution.

 

Second, in a Section 721 transaction, the holding period and tax treatment of a future liquidation of the equity obtained as part of the purchase price follows the holding period and character of the underlying assets sold initially or transferred into the acquiring LLC. In other words, even though the investment in the new LLC may be held longer than a year before it’s liquidated, the ordinary income items of the original transfer still retain their character, and in this case, a portion of the rollover equity would be allocated to the inventory and subject to ordinary income when sold.

 

Issuing equity as part of the purchase price when acquiring a business via a partnership/LLC can benefit both the acquiring entity and the target business when existing management will continue to be involved. Structuring the deal to include rollover equity so that management still has “skin in the game” allows for deferring some of the gain and the potential for even greater reward for all investors down the road.

 

If you have questions on Section 721 or other taxation surrounding mergers & acquisitions, we are here to help! Your M&A team at Shannon & Associates, LLP are experts in tax, accounting, diligence, valuation, and related pre and post-deal planning and execution.  We look forward to hearing from you!

https://www.shannon-cpas.com/services/advisory-services/mergers-acquisitions/


Mark Hale, CPA, Partner

Tax Matters Expert

mhale@shannon-cpas.com


Jeanette Roatch, CPA, CGMA, Partner and Director, Accounting & Auditing

Accounting/Diligence/Q of E Expert

jroatch@shannon-cpas.com


Jessica Norris, CPA, CFE, CVA, Partner

Valuation Matters Expert

jnorris@shannon-cpas.com








Talk to the Experts at Merit Investment Bank

Merit Investment Bank as a leading boutique investment bank is focused on entrepreneurial middle-market companies. Merit Investment Bank Executes sell-side M&A, buy-side M&A, and capital advisory services, debt and equity capital raises, corporate finance, and valuation services. Securities offered through Finalis Securities LLC Member FINRA/SIPC. Merit Investment Bank and Finalis Securities LLC are separate, unaffiliated entities.

WRITE TO US

Securities are offered through Finalis Securities LLC Member FINRA / SIPC. Merit Investment Bank is not a registered broker-dealer, and Finalis Securities LLC and Merit Investment Bank are separate, unaffiliated entities. Finalis Securities LLC, Office of Supervisory Jurisdiction is located at 450 Lexington Ave, New York, NY 10017, 800-962-0418.


Finalis Privacy Policy | Finalis Business Continuity Plan | FINRA BrokerCheck | Finalis Form Customer Relationship Summary ("Form CRS")


www.meritinvestmentbank.com (the "Merit Investment Bank Website") is a website operated by Merit Investment Bank. This website is for informational purposes only, is not an offer, solicitation, recommendation, or commitment for any transaction or to buy or sell any security or other financial product and is not intended as investment advice or as a confirmation of any transaction. Products and services on this website may not be available for residents of certain jurisdictions. Please consult with a Finalis Securities' registered representative regarding the product or service in question for further information. Investments involve risk and are not guaranteed to appreciate. Any market price, indicative value, estimate, view, opinion, data, or other information herein is not warranted as to completeness or accuracy, is subject to change without notice, and Merit Investment Bank along with Finalis Securities LLC accepts no liability for its use or to update it or keep it current.


Investing in private placements involves a high degree of risk. These investments may be illiquid, speculative, and subject to substantial restrictions on transferability. Investors may lose all or part of their investment and should only invest capital they can afford to lose. Prospective investors should conduct their own due diligence and consult with their legal, tax, and financial advisors prior to making any investment decision. For your reference, Finalis' Form CRS describes the services that we provide, how we are compensated, and other important information about Finalis Securities LLC.